2019 annual financial data
Neuphoria Therapeutics 2019 Operating margin
Direct answer
Operating margin was -145.46%.
Operating income was -10.76M USD and net income was -6.77M USD.
Operating cash flow was -10.91M USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7.4M USD
- Operating income
- -10.76M USD
- Net income
- -6.77M USD
- Operating cash flow
- -10.91M USD